Sridhar Nadamuni

As a professional Medical Writer based in Toronto, I work on cutting-edge advances for professionals and consumers alike on issues of topical health interest.

With an M.Sc in life sciences (Biochemistry), and a medical research fellowship in the area of "vitamin D & postmenopausal osteoporosis", I have several years of experience (since November 1995) developing healthcare communications [news reports, blogs, feature articles, outlines, abstracts, manuscripts, literature reviews, posters, and other information and communication vehicles] both for print and online media. I have covered a wide array of health domains including oncology, cardiology, reproductive endocrinology/women's health, geriatric medicine, nutrition, dermatology, infectious and metabolic diseases, psychiatry, complementary therapies including yoga & ayurveda, among others.

My writing career kicked off with the trade publications Express Pharma Pulse and Express Healthcare Management (Mumbai, India). Over the years, I have been published under my own name nationally and internationally in trade journals such as The Medical Post (Toronto); Elsevier Publications (London, UK) including The Lancet Infectious Diseases, The Lancet and Drug Discovery Today; Canadian Medical Association Journal (Ottawa); Canadian Pharmaceutical Journal (Ottawa);National Review of Medicine (Montreal); Nature Biotechnology (NY, USA) and the Italian journal Cosmetic News. I was briefly an Associate Editor for the newsletter Healthy Years (with Belvoir Media Group, Sarasota, FL, USA) supported by the UCLA School of Geriatric Medicine in 2006.

My Web editorial work includes Content Management (2000-'01) for the health portals CardioValens.com, and WebHealthPlus.com. I developed content addressing the information needs of the specialist as well as patient audiences, generating reports on a daily basis.

I was associated with other media outlets in the USA such as The Boston Globe (USA), care-mates.com and demandstudios.com (over 100 articles in 2008).

As a technical consultant to the natural products industry, I generated product dossiers on nutraceuticals and cosmetic ingredients for clients such as Parfums Christian Dior (France) among others. In the area of complementary therapies, I was associated editorially with Heritage Healing (a magazine on complementary therapies published from India) as well as publishing in the SCRIP Magazine (UK) on "Herbal Medicines on the Road to Recognition."I have carried out medical writing projects supported by healthcare and pharmaceutical industry including sanofi-aventis (on atherothrombosis), AstraZeneca (drugs for breast cancer), Amgen (products for cancer-related anemia), Pfizer Oncology (products for cancer-associated thrombosis), Wyeth (depression, hormone replacement therapy), Merck-Frosst (hypertension), 3M (dermatology) and so forth through their agencies--Implementing educational and marketing strategies, blending commercial awareness with scientifically balanced writing in conjunction with key opinion leaders (physicians).

In the year 2002, I worked with the Apotex Pharmachem Inc., Brantford (ON, Canada) reporting to the President/ R&D Director/Manager as Research Associate in a technical information specialist role. Working within a team of researchers (that included senior chemists), I developed patent & literature reviews for R&D addressing their vast repertoire of generic drugs.

In 2003-2004, as a Medical Reviewer for the medico-legal industry in Toronto, I critically reviewed medical and rehabilitation reports of patients written by physicians including orthopedic surgeons, neurologists, physiotherapists, psychiatrists, kinesiologists, chiropractors and so forth.

In 2006, I offered my editorial services to Japanese researchers for peer-reviewed publications in topical areas of medicine and surgery. Some of the topics covered included: Cholesteryl ester transfer protein (CETP) inhibitors: New strategies for management of cardiovascular disease; Lymph node tenderness and pathophysiology of skin disease; Spontaneous Regression of a Growing Vestibular Schwannoma: A Case Report; Metastatic lung germinoma of the thoracic spine: a case report; Docking Simulation Study of Rare Gas Binding to Anesthetic Binding Sites of Human Serum Albumin; Malignant transformation of intracranial mature teratoma to yolk sac tumor after late relapse: a case report; Undifferentiated carcinoma arising from ectopic thyroid tissue in the anterior mediastinum; Role of Lactic Acid Bacteria in Longevity of Caenorhabditis elegans Host Defense to Salmonella enterica Serovar Enteritidis; Subarachnoid hemorrhage due to vertebral artery medullary branch aneurysm: case report and literature review; Is CO2 the most appropriate pneumoperitoneum in laparascopic surgery? Investigating the alternative N2 pneumoperitoneum; In vivo anatomic study of breast circulation using magnetic resonance imaging; Long-term Outcome in Type I Biliary Atresia; Experimental photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX for malignant glioma; Interleukin-10 in the pathophysiology of inflammatory bowel disease: Increased serum concentrations during recovery phase; Notch2 negatively regulates myofibrogenic differentiation by down regulating Notch3; COX-2 and protein aggregates in streptozotocin-induced diabetic mice: Potential role in diabetic nephropathy.

I also attend professional meetings to develop Continuing Medical Education programs for professionals and lay audiences in major therapeutic and clinical areas, for example, Cosmetic and Anti-aging conference (April 2003, Toronto), the first North American Meeting on Severe Acute Respiratory Distress Syndrome (SARS) 2003, American Psychiatry 155th Annual Meeting (Toronto, 2006), International AIDS Congress (Toronto, 2006), and so forth.

Identifying relevant sources, conducting background research and transforming complex scientific and clinical data into professional and consumer-friendly copy, SRIDHAR NADAMUNI offers impeccable and competitive editorial skills for the professional as well as lay audiences.